100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Pharmacology and the Nursing Process, 9th Edition-TEST BANK QUESTIONS AND VERIFIED COMPLETE SOLUTIONS |A+ $21.99
Add to cart

Exam (elaborations)

Pharmacology and the Nursing Process, 9th Edition-TEST BANK QUESTIONS AND VERIFIED COMPLETE SOLUTIONS |A+

 0 view  0 purchase
  • Course
  • NURSING 120
  • Institution
  • NURSING 120

Pharmacology and the Nursing Process, 9th Edition-TEST BANK QUESTIONS AND VERIFIED COMPLETE SOLUTIONS |A+Pharmacology and the Nursing Process, 9th Edition-TEST BANK QUESTIONS AND VERIFIED COMPLETE SOLUTIONS |A+Pharmacology and the Nursing Process, 9th Edition-TEST BANK QUESTIONS AND VERIFIED COM...

[Show more]

Preview 4 out of 311  pages

  • January 8, 2025
  • 311
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:
  • NURSING 120
  • NURSING 120
avatar-seller
Spencejames
Chapter 1 - The Nursing Process and Drug Therapy _____________________ 3
| | | | | | | |



Chapter 2 - Pharmacologic Principles _________________________________ 7
| | | |



Chapter 3 - Lifespan Considerations _________________________________ 13
| | | |



Chapter 4 - Cultural Legal and Ethical Considerations ___________________ 19
| | | | | | |



Chapter 5 - Medication Errors Preventing and Responding _______________ 25
| | | | | | |



Chapter 6 - Patient Education and Drug Therapy _______________________ 29
| | | | | | |



Chapter 7 - Over-the-Counter Drugs and Herbal and Dietary
| | | | | | | |



| Supplements 34 | | Chapter 8 - Gene Therapy and Pharmacogenomics ____ 38 | | | | | |



Chapter 9 - Photo Atlas of Drug Administration ________________________ 42
| | | | | | |



Chapter 10 - Analgesic Drugs ______________________________________ 50
| | | |



Chapter 11 - General and Local Anesthetics ___________________________ 57
| | | | | |



Chapter 12 - Central Nervous System Depressants and Muscle
| | | | | | | |



| Relaxants 61 | | Chapter 13 - Central Nervous System Stimulants and Related
| | | | | | | |



| Drugs _________________________________________________________ 66
Chapter 14 - Antiepileptic Drugs ____________________________________ 70
| | | |



Chapter 15 - Anti-Parkinson Drugs___________________________________ 75
| | | |



Chapter 16 - Psychotherapeutic Drugs _______________________________ 80
| | | |



Chapter 17 - Substance Use Disorder ________________________________ 87
| | | | |



Chapter 18 - Adrenergic Drugs ______________________________________ 92
| | | |



Chapter 19 - Adrenergic-Blocking Drugs ______________________________ 97
| | | |



Chapter 20 - Cholinergic Drugs _____________________________________ 102
| | | |



Chapter 21 - Cholinergic-Blocking Drugs ______________________________ 107
| | | |



Chapter 22 - Antihypertensive Drugs _________________________________ 112
| | | |



Chapter 23 - Antianginal Drugs _____________________________________ 118
| | | |



Chapter 24 - Heart Failure Drugs ____________________________________ 124
| | | | |



Chapter 25 - Antidysrhythmic Drugs _________________________________ 129
| | | |



Chapter 26 - Coagulation Modifier Drugs ______________________________ 134
| | | | |



Chapter 27 - Antilipemic Drugs _____________________________________ 140
| | | |



Chapter 28 - Diuretic Drugs ________________________________________ 145
| | | |



Chapter 29 - Fluids and Electrolytes _________________________________ 151
| | | | |

,Chapter 30 - Pituitary Drugs ________________________________________ 157
| | | |


Chapter 31 - Thyroid and Antithyroid Drugs____________________________ 161
| | | | | |



Chapter 32 - Antidiabetic Drugs _____________________________________ 166
| | | |



Chapter 33 - Adrenal Drugs ________________________________________ 174
| | | |



Chapter 34 - Women’s Health Drugs _________________________________ 178
| | | | |



Chapter 35 - Men’s Health Drugs ___________________________________ 185
| | | | |



Chapter 36 - Antihistamines Decongestants Antitussives and Expectorants
| | | | | | |



| 189 Chapter 37 - Respiratory Drugs _________________________________ 194
| | | | |



Chapter 38 - Antibiotics Part 1 ______________________________________ 199
| | | | |



Chapter 39 - Antibiotics Part 2 ______________________________________ 206
| | | | |



Chapter 40 - Antiviral Drugs ________________________________________ 211
| | | |



Chapter 41 - Antitubercular Drugs ___________________________________ 216
| | | |



Chapter 42 - Antifungal Drugs ______________________________________ 221
| | | |



Chapter 43 - Antimalarial Antiprotozoal and Anthelmintic Drugs ____________ 226
| | | | | | |



Chapter 44 - Anti-inflammatory and Antigout Drugs _____________________ 231
| | | | | |



Chapter 45 - Antineoplastic Drugs Part 1 Cancer Overview and Cell
| | | | | | | | | |



| Cycle 236 Chapter 46 - Antineoplastic Drugs Part 2 Cell Cycle Nonspecific and
| | | | | | | | | | | |



| Misc.
Drugs _________________________________________________________ 242
Chapter 47 - Biologic Response–Modifying and Antirheumatic Drugs _______ 247
| | | | | | |



Chapter 48 - Immunosuppressant Drugs ______________________________ 252
| | | |



Chapter 49 - Immunizing Drugs _____________________________________ 257
| | | |



Chapter 50 - Acid-Controlling Drugs__________________________________ 262
| | | |



Chapter 51 - Bowel Disorder Drugs __________________________________ 268
| | | | |



Chapter 52 - Antiemetic and Antinausea Drugs ________________________ 275
| | | | | |



Chapter 53 - Vitamins and Minerals__________________________________ 280
| | | | |



Chapter 54 - Anemia Drugs ________________________________________ 286
| | | |



Chapter 55 - Nutritional Supplements ________________________________ 292
| | | |



Chapter 56 - Drugs _______________________________________________ 296
| | |



Chapter 57 - Ophthalmic Drugs _____________________________________ 302
| | | |

,Chapter 58 - Otic Drugs ___________________________________________ 307
| | | |

, 3

Chapter 01: The Nursing Process and Drug Therapy
| | | | | | |

Lilley: Pharmacology and the Nursing Process, 9th Edition
| | | | | | | |




MULTIPLE |CHOICE

1. The |nurse |is |developing |a |human |needs |statement |for |a |patient |who |has |a |new |diagnosis |of
|heart |failure. |Identification |of |human |needs |statements |occur |with |which |of |these
|activities?

a. Collection |of |patient |data
b. Administering |interventions
c. Deciding |on |patient |outcomes
d. Documenting |the |patient’s |behavior
ANS: | A
Identification |of |human |needs |occurs |with |the |collection |of |patient |data.

DIF: Cognitive |Level: |Understanding |(Comprehension)
|TOP: | Nursing |Process: |Human |Needs |Statement

MSC: | NCLEX: |Safe |and |Effective |Care |Environment: |Management |of |Care

2. The |patient |is |to |receive |oral |guaifenesin |(Mucinex) |twice |a |day. |Today, |the |nurse |was
|busy |and |gave |the |medication |2 |hours |after |the |scheduled |dose |was |due. |What |type
|of |problem |does |this |represent?

a. “Right |time”
b. “Right |dose”
c. “Right |route”
d. “Right |medication”
ANS: | A
“Right |time” |is |correct |because |the |medication |was |given |more |than |30 |minutes |after |the
|scheduled |dose |was |due. |“Dose” |is |incorrect |because |the |dose |is |not |related |to |the |time |the

|medication |administration |is |scheduled. |“Route” |is |incorrect |because |the |route |is |not

|affected. |“Medication” |is |incorrect |because |the |medication |ordered |will |not |change.




DIF: Cognitive |Level: |Applying |(Application)
|TOP: | Nursing |Process: |Implementation

MSC: | NCLEX: |Safe |and |Effective |Care |Environment: |Safety |and |Infection |Control

3. The |nurse |has |been |monitoring |the |patient’s |progress |on |a |new |drug |regimen |since |the
|first |dose |and |documenting |the |patient’s |therapeutic |response |to |the |medication. |Which
|phase |of |the |nursing |process |do |these |actions |illustrate?

a. Human |needs |statement
b. Planning
c. Implementation
d. Evaluation
ANS: | D
Monitoring |the |patient’s |progress, |including |the |patient’s |response |to |the |medication, |is
|part |of |the |evaluation |phase. |Planning, |implementation, |and |human |needs |statement |are |not

|illustrated |by |this |example.




Chapter |1 |- |The |Nursing |Process |and |Drug 3
|Therapy

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Spencejames. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $21.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

51292 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling
$21.99
  • (0)
Add to cart
Added